Data / Form D filings / Theradaptive, Inc.
Theradaptive, Inc.: Form D filing
Theradaptive, Inc., a biotechnology company in Frederick, MD, filed a Form D with the SEC in 2026. The latest, on August 4, 2026, reports $36.2 million sold of a $77.9 million offering to 65 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 7495 New Horizon Way, Suite 240, Frederick, MD, 21703
- Phone
- (617) 454-4050
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2148461
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 4, 2026 | New notice | $77,925,166 | $36,156,177 | $41,768,989 | 65 | Jul 21, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Luis Alvarez | Executive Officer, Director | |
| David Stewart | Executive Officer, Director | |
| Ted A. Meyers | Director | |
| George Shanine | Director | |
| Patrick Zhang | Director | |
| David Harrington | Director | |
| Jeffrey Dunn | Director |
Other biotechnology companies in Maryland that filed recently
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
Every Form D from the week of Aug 3, 2026 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Theradaptive, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.